DaVita
DVA
#2251
Rank
HK$63.23 B
Marketcap
HK$884.41
Share price
-0.16%
Change (1 day)
-23.95%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): HK$77.47

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$77.36. In 2024 the company made an earnings per share (EPS) of HK$85.84 an increase over its 2023 EPS that were of HK$59.23.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$77.47-9.76%
2024HK$85.8444.94%
2023HK$59.2327.26%
2022HK$46.54-35.56%
2021HK$72.2244.1%
2020HK$50.1219.7%
2019HK$41.87540.48%
2018HK$6.54-76.07%
2017HK$27.32-19.31%
2016HK$33.85242.52%
2015HK$9.88-62.87%
2014HK$26.6213.43%
2013HK$23.468.45%
2012HK$21.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
HK$114.40 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$14.78-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
HK$166.16 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$79.77 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA